Sativa hires director of regulatory affairs to launch CBD vet services

Sativa Investments, UK-based medicinal cannabis investment vehicle, has appointed Dr Nick Horniman BVSc MRCVS as its director of regulatory affairs with immediate effect.

In his new senior management role, Horniman has been appointed to coordinate the company’s overall regulatory strategy and ongoing relationships with regulators.

He will also implement the company’s licencing strategy through its continuing relationships with the relevant UK agencies and research centres surrounding the regulation of the cultivation of cannabis. This includes the company’s engagement in research and export opportunities, growing licences for the cultivation of cannabis for supply to pharmaceutical manufacturers and working with the Veterinary Medicines Directorate to explore the use of cannabis-based products for the treatment of animals, particularly the dog and cat pet market and the equine industry.